Cargando…

A cross-sectional mixed methods protocol to describe correlates and explanations for a long duration of untreated psychosis among patients with first episode psychosis in Uganda

INTRODUCTION: Among patients with psychotic disorders, the ‘duration of untreated psychosis’ (DUP) is a predictor of key outcomes such as symptom remission and quality of life. In sub-Saharan Africa, DUP is up to five times longer than in high-income countries, with many patients going without antip...

Descripción completa

Detalles Bibliográficos
Autores principales: Mwesiga, Emmanuel Kiiza, Nakasujja, Noeline, Ongeri, Linnet, Semeere, Aggrey, Loewy, Rachel, Meffert, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661643/
https://www.ncbi.nlm.nih.gov/pubmed/31315866
http://dx.doi.org/10.1136/bmjopen-2018-028029
_version_ 1783439492100653056
author Mwesiga, Emmanuel Kiiza
Nakasujja, Noeline
Ongeri, Linnet
Semeere, Aggrey
Loewy, Rachel
Meffert, Susan
author_facet Mwesiga, Emmanuel Kiiza
Nakasujja, Noeline
Ongeri, Linnet
Semeere, Aggrey
Loewy, Rachel
Meffert, Susan
author_sort Mwesiga, Emmanuel Kiiza
collection PubMed
description INTRODUCTION: Among patients with psychotic disorders, the ‘duration of untreated psychosis’ (DUP) is a predictor of key outcomes such as symptom remission and quality of life. In sub-Saharan Africa, DUP is up to five times longer than in high-income countries, with many patients going without antipsychotic medication for 5 years or longer. One contributor to this high DUP may relate to cultural norms that drive use of alternative and complementary therapies (ACTs) as first-line treatment strategies, rather than biomedical care with antipsychotic medicine. We aim to (1) determine the prevalence and factors associated with DUP and ACT use in Uganda, and (2) Identify factors that drive patient and family choices to use ACT as a first-line treatment strategy. METHODS AND ANALYSIS: We will leverage on an ongoing cohort study at the national psychiatric and teaching hospital in Uganda. The parent study is an observational cohort design following antipsychotic naïve adults with a first episode of psychosis without substance use, HIV/AIDS or syphilis. The embedded study will use a mixed methods design including quantitative assessment of parent study participants with the Nottingham Onset Schedule-DUP to determine the DUP. Qualitative assessment will focus on patient and caregiver perceptions and use of ACT and its impact on DUP among patients with psychosis using in-depth interviews. ETHICS AND DISSEMINATION: The study has received ethical approval from the school of medicine research and ethics committee of the college of health sciences at Makerere University. It has also received institutional support to perform the study from the Infectious Diseases Institute and Butabika hospital. Besides publication of the work in reputable peer-reviewed journals, we hope that this work will lead to evidence-based discussions on the need for early interventions to reduce DUP in Uganda.
format Online
Article
Text
id pubmed-6661643
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-66616432019-08-07 A cross-sectional mixed methods protocol to describe correlates and explanations for a long duration of untreated psychosis among patients with first episode psychosis in Uganda Mwesiga, Emmanuel Kiiza Nakasujja, Noeline Ongeri, Linnet Semeere, Aggrey Loewy, Rachel Meffert, Susan BMJ Open Global Health INTRODUCTION: Among patients with psychotic disorders, the ‘duration of untreated psychosis’ (DUP) is a predictor of key outcomes such as symptom remission and quality of life. In sub-Saharan Africa, DUP is up to five times longer than in high-income countries, with many patients going without antipsychotic medication for 5 years or longer. One contributor to this high DUP may relate to cultural norms that drive use of alternative and complementary therapies (ACTs) as first-line treatment strategies, rather than biomedical care with antipsychotic medicine. We aim to (1) determine the prevalence and factors associated with DUP and ACT use in Uganda, and (2) Identify factors that drive patient and family choices to use ACT as a first-line treatment strategy. METHODS AND ANALYSIS: We will leverage on an ongoing cohort study at the national psychiatric and teaching hospital in Uganda. The parent study is an observational cohort design following antipsychotic naïve adults with a first episode of psychosis without substance use, HIV/AIDS or syphilis. The embedded study will use a mixed methods design including quantitative assessment of parent study participants with the Nottingham Onset Schedule-DUP to determine the DUP. Qualitative assessment will focus on patient and caregiver perceptions and use of ACT and its impact on DUP among patients with psychosis using in-depth interviews. ETHICS AND DISSEMINATION: The study has received ethical approval from the school of medicine research and ethics committee of the college of health sciences at Makerere University. It has also received institutional support to perform the study from the Infectious Diseases Institute and Butabika hospital. Besides publication of the work in reputable peer-reviewed journals, we hope that this work will lead to evidence-based discussions on the need for early interventions to reduce DUP in Uganda. BMJ Publishing Group 2019-07-16 /pmc/articles/PMC6661643/ /pubmed/31315866 http://dx.doi.org/10.1136/bmjopen-2018-028029 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Global Health
Mwesiga, Emmanuel Kiiza
Nakasujja, Noeline
Ongeri, Linnet
Semeere, Aggrey
Loewy, Rachel
Meffert, Susan
A cross-sectional mixed methods protocol to describe correlates and explanations for a long duration of untreated psychosis among patients with first episode psychosis in Uganda
title A cross-sectional mixed methods protocol to describe correlates and explanations for a long duration of untreated psychosis among patients with first episode psychosis in Uganda
title_full A cross-sectional mixed methods protocol to describe correlates and explanations for a long duration of untreated psychosis among patients with first episode psychosis in Uganda
title_fullStr A cross-sectional mixed methods protocol to describe correlates and explanations for a long duration of untreated psychosis among patients with first episode psychosis in Uganda
title_full_unstemmed A cross-sectional mixed methods protocol to describe correlates and explanations for a long duration of untreated psychosis among patients with first episode psychosis in Uganda
title_short A cross-sectional mixed methods protocol to describe correlates and explanations for a long duration of untreated psychosis among patients with first episode psychosis in Uganda
title_sort cross-sectional mixed methods protocol to describe correlates and explanations for a long duration of untreated psychosis among patients with first episode psychosis in uganda
topic Global Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661643/
https://www.ncbi.nlm.nih.gov/pubmed/31315866
http://dx.doi.org/10.1136/bmjopen-2018-028029
work_keys_str_mv AT mwesigaemmanuelkiiza acrosssectionalmixedmethodsprotocoltodescribecorrelatesandexplanationsforalongdurationofuntreatedpsychosisamongpatientswithfirstepisodepsychosisinuganda
AT nakasujjanoeline acrosssectionalmixedmethodsprotocoltodescribecorrelatesandexplanationsforalongdurationofuntreatedpsychosisamongpatientswithfirstepisodepsychosisinuganda
AT ongerilinnet acrosssectionalmixedmethodsprotocoltodescribecorrelatesandexplanationsforalongdurationofuntreatedpsychosisamongpatientswithfirstepisodepsychosisinuganda
AT semeereaggrey acrosssectionalmixedmethodsprotocoltodescribecorrelatesandexplanationsforalongdurationofuntreatedpsychosisamongpatientswithfirstepisodepsychosisinuganda
AT loewyrachel acrosssectionalmixedmethodsprotocoltodescribecorrelatesandexplanationsforalongdurationofuntreatedpsychosisamongpatientswithfirstepisodepsychosisinuganda
AT meffertsusan acrosssectionalmixedmethodsprotocoltodescribecorrelatesandexplanationsforalongdurationofuntreatedpsychosisamongpatientswithfirstepisodepsychosisinuganda
AT mwesigaemmanuelkiiza crosssectionalmixedmethodsprotocoltodescribecorrelatesandexplanationsforalongdurationofuntreatedpsychosisamongpatientswithfirstepisodepsychosisinuganda
AT nakasujjanoeline crosssectionalmixedmethodsprotocoltodescribecorrelatesandexplanationsforalongdurationofuntreatedpsychosisamongpatientswithfirstepisodepsychosisinuganda
AT ongerilinnet crosssectionalmixedmethodsprotocoltodescribecorrelatesandexplanationsforalongdurationofuntreatedpsychosisamongpatientswithfirstepisodepsychosisinuganda
AT semeereaggrey crosssectionalmixedmethodsprotocoltodescribecorrelatesandexplanationsforalongdurationofuntreatedpsychosisamongpatientswithfirstepisodepsychosisinuganda
AT loewyrachel crosssectionalmixedmethodsprotocoltodescribecorrelatesandexplanationsforalongdurationofuntreatedpsychosisamongpatientswithfirstepisodepsychosisinuganda
AT meffertsusan crosssectionalmixedmethodsprotocoltodescribecorrelatesandexplanationsforalongdurationofuntreatedpsychosisamongpatientswithfirstepisodepsychosisinuganda